tiprankstipranks
Trending News
More News >
Evaxion Biotech (EVAX)
NASDAQ:EVAX
US Market

Evaxion Biotech (EVAX) Cash flow

Compare
402 Followers

Evaxion Biotech Cash Flow

EVAX's free cash flow for Q4 2025 was $-6.66M. For the 2025 fiscal year, EVAX's free cash flow was decreased by $6.28M and operating cash flow was $-6.65M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Mar 25Dec 23Mar 23Dec 21
Operating Cash Flow
$ -6.65M$ -12.94M$ -17.69M$ -25.77M$ -21.93M
Investing Cash Flow
$ -14.04K$ -3.00K$ -93.00K$ -268.00K$ -1.33M
Financing Cash Flow
$ 22.48M$ 13.13M$ 10.69M$ 7.85M$ 49.80M
End Cash Position
$ 23.23M$ 5.95M$ 5.58M$ 13.18M$ 32.17M
Free Cash Flow
$ -6.66M$ -12.94M$ -17.78M$ -26.07M$ -23.29M
Currency in USD

Evaxion Biotech Cash Flow